Concepedia

Author

Alex H. Chang

Shanghai Pulmonary HospitalORCID

Also Known As

A Chang, A H Chang, A. CHANG, A. Chang, A. H. Chang, Alex Chang, Alex H Chang, Alex H. C. Chang, Alex H. Chang, Alex H.C Chang

147

Publications

3.3K

Citations

31

H-Index

76

Concepts

All Affiliations

Shanghai Pulmonary HospitalTongji UniversityZhejiang UniversityBeijing Tongren HospitalChinese Academy of Medical Sciences & Peking Union Medical College
AH

About

Alex H. Chang is an author at Shanghai Pulmonary Hospital specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

18

1.2K

2

Health Sciences

4

4

144

3

Social Sciences

1

1

37

4

Allergy

1

1

55

5

Biomedical Engineering

1

1

38

Alex H. Chang

×

49

Publications

3K

Citations

29

H-Index

YearCitations

T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

Matthias T. Stephan, Vladimir Ponomarev, Renier J. Brentjens,

Nature Medicine

2007

289

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang,

Journal of Clinical Oncology

2021

280

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Jing Pan, Qing Niu, Biping Deng,

Leukemia

2019

242

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

Shuangyou Liu, Biping Deng, Zhichao Yin,

Blood Cancer Journal

2020

151

Inhibition of the Self-cleavage Reaction of the Human Hepatitis Delta Virus Ribozyme by Antibiotics

Jeff Rogers, Alex H. Chang, Uwe von Ahsen,

Journal of Molecular Biology

1996

137

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma

Jiasheng Wang, Yongxian Hu, Shuye Yang,

Biology of Blood and Marrow Transplantation

2019

127

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

Yongxian Hu, Jingjing Li, Fang Ni,

Nature Communications

2022

126

Combination of <scp>CD19</scp> and <scp>CD22 CAR‐T</scp> cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation

Shuangyou Liu, Biping Deng, Zhichao Yin,

American Journal of Hematology

2021

119

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

Jieyun Xia, Hujun Li, Zhiling Yan,

Journal of Clinical Oncology

2023

85

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Jing Pan, Biping Deng, Zhuojun Ling,

Journal of Cellular and Molecular Medicine

2020

83

Page 1